We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.53%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$6.09B
AUM Growth
+$393M
(+6.9%)
Cap. Flow
-$95.1M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
956
New
52
Increased
378
Reduced
294
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lazard
LAZ
|
+$10.7M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$8.34M |
| 3 |
Cisco
CSCO
|
+$8.11M |
| 4 |
FRC
First Republic Bank
FRC
|
+$7.27M |
| 5 |
Phillips 66
PSX
|
+$6.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$39M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$11.6M |
| 3 |
Target
TGT
|
+$10.9M |
| 4 |
GE Aerospace
GE
|
+$10.3M |
| 5 |
PNC Financial Services
PNC
|
+$8.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.83% |
| 2 | Healthcare | 16% |
| 3 | Technology | 10.83% |
| 4 | Communication Services | 9.48% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
651
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $227K | ﹤0.01% |
24,000
+500
| +2% | +$3.57K |
|
652
Equity Residential
EQR
$25.1B
| $226K | ﹤0.01% |
4,362
-2,440
| -36% | -$129K |
|
|
ARII
653
DELISTED
American Railcar Industries, Inc.
ARII
| $223K | ﹤0.01% |
+4,900
| New | +$210K |
|
654
Boston Properties
BXP
$11.1B
| $221K | ﹤0.01% |
2,200
-1,135
| -34% | -$117K |
|
655
Vornado Realty Trust
VNO
$7.38B
| $220K | ﹤0.01% |
3,345
-1,252
| -27% | -$81.1K |
|
|
ECYT
656
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $220K | ﹤0.01% |
20,700
+600
| +3% | +$6.63K |
|
|
COL
657
DELISTED
Rockwell Collins
COL
| $219K | ﹤0.01% |
2,956
-700
| -19% | -$49.7K |
|
|
Y
658
DELISTED
Alleghany Corp
Y
| $215K | ﹤0.01% |
545
| – | – |
|
|
ERF
659
DELISTED
Enerplus Corporation
ERF
| $214K | ﹤0.01% |
11,898
| – | – |
|
660
Pitney Bowes
PBI
$2.39B
| $212K | ﹤0.01% |
9,000
| – | – |
|
661
Moody's
MCO
$82.7B
| $204K | ﹤0.01% |
2,634
+1,383
| +111% | +$101K |
|
|
CTRA
662
DELISTED
Coterra Energy
CTRA
| $199K | ﹤0.01% |
5,108
-18,625
| -78% | -$665K |
|
663
O-I Glass
OI
$1.08B
| $199K | ﹤0.01% |
5,615
| – | – |
|
|
SCG
664
DELISTED
Scana
SCG
| $199K | ﹤0.01% |
4,227
-12,500
| -75% | -$585K |
|
665
EQT Corp
EQT
$32.3B
| $197K | ﹤0.01% |
3,995
| – | – |
|
666
TIM SA
TIMB
$8.8B
| $196K | ﹤0.01% |
+7,500
| New | +$189K |
|
|
IMMU
667
DELISTED
Immunomedics Inc
IMMU
| $196K | ﹤0.01% |
47,100
+1,000
| +2% | +$4.45K |
|
668
Pacific Biosciences
PACB
$370M
| $195K | ﹤0.01% |
37,300
+3,500
| +10% | +$16.1K |
|
669
Omeros
OMER
$959M
| $190K | ﹤0.01% |
17,000
+500
| +3% | +$4.82K |
|
|
FLG
670
Flagstar Bank National Association
FLG
$5.82B
| $189K | ﹤0.01% |
3,769
+1,186
| +46% | +$57.5K |
|
|
PGNX
671
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $189K | ﹤0.01% |
34,500
+1,000
| +3% | +$4.4K |
|
|
AMRI
672
DELISTED
Albany Molecular Research Inc
AMRI
| $182K | ﹤0.01% |
17,800
+500
| +3% | +$6.04K |
|
|
AMRN
673
Amarin Corp
AMRN
$303M
| $181K | ﹤0.01% |
4,685
+710
| +18% | +$36.8K |
|
674
Thomson Reuters
TRI
$44.1B
| $179K | ﹤0.01% |
+4,050
| New | +$173K |
|
|
ACHN
675
DELISTED
Achillion Pharmaceuticals
ACHN
| $179K | ﹤0.01% |
55,000
+1,000
| +2% | +$2.9K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2013 Portfolio in Review
As of Q4 2013, DekaBank Deutsche Girozentrale held 956 positions worth $6.09B, up 6.9% from $5.69B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
DekaBank Deutsche Girozentrale's Q4 2013 filing shows 52 new, 378 increased, 294 reduced and 42 closed positions. Its largest new stake was Lazard: 264,565 shares worth $11.9M. The largest sale was Deutsche Bank, an estimated $39M.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Technology.
- DekaBank Deutsche Girozentrale's largest Q4 2013 buy was Lazard: 264,565 shares worth $11.9M.
- DekaBank Deutsche Girozentrale added most to QIAGEN NV in Q4 2013, an estimated $8.34M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2013 reduction was Deutsche Bank, cutting an estimated $39M.
- DekaBank Deutsche Girozentrale fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $5.92M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 33% of its $6.09B portfolio in Q4 2013.
- DekaBank Deutsche Girozentrale opened 52 new positions and closed 42 in Q4 2013.
- DekaBank Deutsche Girozentrale's portfolio value rose 6.9% quarter-over-quarter to $6.09B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2013, filed 11 Feb 2014.